Mounting evidence suggests that dietary caffeine intake may exert some beneficial effects in reducing dementia risk and possibly Alzheimer’s disease, and may be a viable therapeutic approach. Clinical studies also suggest that caffeine is a cognitive normalizer and not a cognitive enhancer. Moreover, some clinical studies suggest the neuroprotective effect of caffeine might be confounded by gender.
University of Galway
This project aims to evaluate the effectiveness of CS-ADL (Cognitive Stimulation in Activities of Daily Living). CS-ADL is an occupational therapist-led, group cognitive stimulation program for people living with mild-to-moderate dementia that aims to enhance their functional performance, alongside their social and cognitive functioning.